Corticosteroid Treatment for Acute Gout in Elderly Men

First-Line Treatment Options

• The American College of Rheumatology recommends oral prednisone at 0.5 mg/kg per day for 5-10 days at full dose and then stopped, or alternatively given for 2-5 days at full dose followed by tapering for 7-10 days 1
• Corticosteroids are considered a first-line therapy for acute gout in elderly patients, particularly when NSAIDs and colchicine are contraindicated or poorly tolerated 1

Alternative Administration Routes

• For involvement of only 1-2 large joints, intra-articular corticosteroid injection is recommended, with dose varying depending on joint size 1
• Intramuscular triamcinolone acetonide 60 mg, followed by oral prednisone, is another effective alternative route of administration 1

Evidence Supporting Corticosteroid Efficacy

• Multiple randomized trials have shown that oral corticosteroids are as effective as NSAIDs for treating acute gout, with fewer adverse events 2
• In one study of 90 patients with acute gout, prednisolone 30 mg/day for 5 days was as effective as indomethacin but with significantly fewer adverse events (27% vs. 63%) 2

Dosing Considerations for Elderly Patients

• A starting dose of 30-35 mg of prednisone daily for 5 days is supported by high-quality evidence (Level A) 1
• For severe attacks, consider a slightly higher initial dose with a tapering schedule over 7-10 days 1

Monitoring and Precautions

• Monitor for short-term adverse effects including dysphoria, mood disorders, elevated blood glucose levels, and fluid retention 1
• For elderly patients with diabetes, more frequent blood glucose monitoring is recommended during the steroid course 3
• Avoid long-term corticosteroid use for gout prophylaxis; if needed, use low-dose prednisone (≤10 mg/day) only when colchicine and NSAIDs are contraindicated 4, 5

Prophylaxis During Urate-Lowering Therapy

• For prophylaxis during initiation of urate-lowering therapy, low-dose prednisone (<10 mg/day) can be used as a second-line option if colchicine and NSAIDs are not tolerated 4, 5
• Continue prophylaxis for at least 6 months or until 3 months after achieving target serum urate in patients without tophi 4, 5